ViroTCell will be administered to patients treated at the Vall d’Hebron University Hospital’s (Vall d’Hebron Barcelona Hospital Campus) recently inaugurated Advanced Cell Therapy Unit. Supported by the Fundación Vila Casas, this Unit is the first facility in Spain that is exclusively focused on novel cell-based therapies against cancer and is particularly dedicated to advancing the treatment and care of patients suffering from blood and lymph node cancers.
Source: BioTech